ArticleNeoplasia (New York, N.Y.)2025

EGFL6 is a novel HER3 ligand, inducing HER3/integrin heterodimers to induce pERK centrosomal deposition and therapeutic resistance.

Shoumei Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.